Detection of spirochaetal microorganisms by focus floating microscopy in necrobiosis lipoidica in patients from central Europe

Histopathology

Volumn 52, Issue 7, 2008, Pages 877-884

  Eisendle, K ^a   Baltaci, M ^a   Kutzner, H ^b   Zelger, B ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Dermatohistology Laboratory   (Germany)

Author keywords

Borrelia burgdorferi; Focus floating microscopy; Immunhistochemistry; Lyme disease; Necrobiosis lipoidica; PCR

Indexed keywords

RNA;

ACRODERMATITIS CHRONICA ATROPHICANS; ADULT; ARTICLE; BORRELIA; BORRELIA BURGDORFERI; CONTROLLED STUDY; EUROPE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; NECROBIOSIS LIPOIDICA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPIROCHETE; TISSUE SECTION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD20; BIOLOGICAL MARKERS; BORRELIA BURGDORFERI GROUP; BORRELIA INFECTIONS; CHILD; DNA, BACTERIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; MIDDLE AGED; NECROBIOSIS LIPOIDICA; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; SKIN;

BORRELIA; BORRELIA BURGDORFERI; SPIROCHAETES;

EID: 44249118089     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.03051.x     Document Type: Article

References (48)

1. Muller SA, Winkelmann RK. Necrobiosis lipoidica diabeticorum. A clinical and pathological investigation of 171 cases. Arch. Dermatol. 1966 93 272 281.
2. Lowitt MH, Dover JS. Necrobiosis lipoidica. J. Am. Acad. Dermatol. 1991 25 735 748.
3. Muller SA, Winkelmann RK. Necrobiosis lipoidica diabeticorum histopathologic study of 98 cases. Arch. Dermatol. 1966 94 1 10.
4. O'Toole EA, Kennedy U, Nolan JJ, Young MM, Rogers S, Barnes L. Necrobiosis lipoidica: only a minority of patients have diabetes mellitus. Br. J. Dermatol. 1999 140 283 286.
5. Cioc AM, Frambach GE, Magro CM. Light-chain-restricted plasmacellular infiltrates in necrobiosis lipoidica - a clue to an underlying monoclonal gammopathy. J. Cutan. Pathol. 2005 32 263 267.
6. Magro CM, Crowson AN, Regauer S. Granuloma annulare and necrobiosis lipoidica tissue reactions as a manifestation of systemic disease. Hum. Pathol. 1996 27 50 56.
7. Whorwell PJ, Haboubi NY, Du Boulay C. Nodular necrobiosis in association with ulcerative colitis. Gut 1986 27 1517.
8. Cohen O, Yaniv R, Karasik A, Trau H. Necrobiosis lipoidica and diabetic control revisited. Med. Hypotheses 1996 46 348.
9. Eisendle K, Grabner T, Zelger B. Focus floating microscopy: "gold standard" for cutaneous borreliosis? Am. J. Clin. Pathol. 2007 127 1 10.
10. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP. Lyme disease - a tick-borne spirochetosis? Science 1982 216 1317 1319.
11. Duray PH. The surgical pathology of human Lyme disease. An enlarging picture. Am. J. Surg. Pathol. 1987 11 (Suppl. 1 47 60.
12. Wormser GP. Clinical practice: early Lyme disease. N. Engl. J. Med. 2006 354 2794 2801.
13. Stanek G, Strle F. Lyme borreliosis. Lancet 2003 362 1639 1647.
14. Schmutzhard E, Stanek G, Pletschette M et al. Infections following tickbites. Tick borne encephalitis and Lyme borreliosis - a prospective epidemiological study from Tyrol. Infection 1988 16 269 272.
15. Plorer A, Sepp N, Schmutzhard E et al. Effects of adequate versus inadequate treatment of cutaneous manifestations of Lyme borreliosis on the incidence of late complications and late serologic status. J. Invest. Dermatol. 1993 100 103 109.
16. Schwartz JJ, Gazumyan A, Schwartz I. rRNA gene organization in the Lyme disease spirochete, Borrelia burgdorferi. J. Bacteriol. 1992 174 3757 3765.
17. Duray PH, Steere AC. Clinical pathologic correlations of Lyme disease by stage. Ann. NY Acad. Sci. 1988 539 65 79.
18. Aberer E, Duray PH. Morphology of Borrelia burgdorferi: structural patterns of cultured borreliae in relation to staining methods. J. Clin. Microbiol. 1991 29 764 772.
19. Aberer E, Kersten A, Klade H, Poitschek C, Jurecka W. Heterogeneity of Borrelia burgdorferi in the skin. Am. J. Dermatopathol. 1996 18 571 579.
20. MacDonald AB. A life cycle for Borrelia spirochetes? Med. Hypotheses 2006 67 810 818.
21. Quimby SR, Muller SA, Schroeter AL. The cutaneous immunopathology of necrobiosis lipoidica diabeticorum. Arch. Dermatol. 1988 124 1364 1371.
22. Haralambous S, Blackwell C, Mappouras DG, Weir DM, Kemmett D, Lymberi P. Increased natural autoantibody activity to cytoskeleton proteins in sera from patients with necrobiosis lipoidica, with or without insulin-dependent diabetes mellitus. Autoimmunity 1995 20 267 275.
23. Crosby DL, Woodley DT, Leonard DD. Concomitant granuloma annulare and necrobiosis lipoidica. Report of a case and review of the literature. Dermatologica 1991 183 225 229.
24. Berkson MH, Bondi EE, Margolis DJ. Ulcerated necrobiosis lipoidica diabeticorum in a patient with a history of generalized granuloma annulare. Cutis 1994 53 85 86.
25. Marchetti F, Gerarduzzi T, Longo F, Faleschini E, Ventura A, Tonini G. Maturity-onset diabetes of the young with necrobiosis lipoidica and granuloma annulare. Pediatr. Dermatol. 2006 23 247 250.
26. Ullman S, Dahl MV. Necrobiosis lipoidica. An immunofluorescence study. Arch. Dermatol. 1977 113 1671 1673.
27. Evans CD, Pereira RS, Yuen CT, Holden CA. Anti-collagen antibodies in granuloma annulare and necrobiosis lipoidica. Clin. Exp. Dermatol. 1988 13 252 254.
28. Mensing H. Clofazimine - therapeutic alternative in necrobiosis lipoidica and granuloma anulare. Hautarzt 1989 40 99 103.
29. Volden G. Successful treatment of chronic skin diseases with clobetasol propionate and a hydrocolloid occlusive dressing. Acta Derm. Venereol. 1992 72 69 71.
30. Rubel DM, Wood G, Rosen R, Jopp-McKay A. Generalised granuloma annulare successfully treated with pentoxifylline. Australas. J. Dermatol. 1993 34 103 108.
31. Hertl MS, Haendle I, Schuler G, Hertl M. Rapid improvement of recalcitrant disseminated granuloma annulare upon treatment with the tumour necrosis factor-alpha inhibitor, infliximab. Br. J. Dermatol. 2005 152 552 555.
32. Strle F, Preac-Mursic V, Ruzic E, Wilske B, Cimperman J. Isolation of Borrelia burgdorferi from a skin lesion in a patient with granuloma annulare. Infection 1991 19 351 352.
33. Aberer E, Schmidt BL, Breier F, Kinaciyan T, Luger A. Amplification of DNA of Borrelia burgdorferi in urine samples of patients with granuloma annulare and lichen sclerosus et atrophicus. Arch. Dermatol. 1999 135 210 212.
34. Schewe C, Rizello M, Dietel M, Hauptmann S. PCR based diagnosis in pathology. Pathologe 2000 21 218 228.
35. Melchers W, Meis J, Rosa P et al. Amplification of Borrelia burgdorferi DNA in skin biopsies from patients with Lyme disease. J. Clin. Microbiol. 1991 29 2401 2406.
36. Moter SE, Hofmann H, Wallich R, Simon MM, Kramer MD. Detection of Borrelia burgdorferi sensu lato in lesional skin of patients with erythema migrans and acrodermatitis chronica atrophicans by ospA-specific PCR. J. Clin. Microbiol. 1994 32 2980 2988.
37. von Stedingk LV, Olsson I, Hanson HS, Asbrink E, Hovmark A. Polymerase chain reaction for detection of Borrelia burgdorferi DNA in skin lesions of early and late Lyme borreliosis. Eur. J. Clin. Microbiol. Infect. Dis. 1995 14 1 5.
38. Picken MM, Picken RN, Han D et al. A two year prospective study to compare culture and polymerase chain reaction amplification for the detection and diagnosis of Lyme borreliosis. J. Clin. Pathol. Mol. Pathol. 1997 50 186 193.
39. Rebaudet S, Parola P. Epidemiology of relapsing fever borreliosis in Europe. FEMS Immunol. Med. Microbiol. 2006 48 11 15.
40. Foldvari G, Farkas R, Lakos A. Borrelia spielmanii erythema migrans, Hungary. Emerg. Infect. Dis. 2005 11 1794 1795.
41. van Dam AP, Kuiper H, Vos K et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin. Infect. Dis. 1993 17 708 717.
42. Singh SK, Girschick HJ. Lyme borreliosis: from infection to autoimmunity. Clin. Microbiol. Infect. 2004 10 598 614.
43. Benoist C, Mathis D. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat. Immunol. 2001 2 797 801.
44. Willett TA, Meyer AL, Brown EL, Huber BT. An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitope. Proc. Natl Acad. Sci. U S A 2004 101 1303 1308.
45. Steere AC, Gross D, Meyer AL, Huber BT. Autoimmune mechanisms in antibiotic treatment-resistant lyme arthritis. J. Autoimmun. 2001 16 263 268.
46. Behar SM, Porcelli SA. Mechanisms of autoimmune disease induction. The role of the immune response to microbial pathogens. Arthritis Rheum. 1995 38 458 476.
47. Murray CA, Miller RA. Necrobiosis lipoidica diabeticorum and thyroid disease. Int. J. Dermatol. 1997 36 799 800.
48. Benvenga S, Santarpia L, Trimarchi F, Guarneri F. Human thyroid autoantigens and proteins of Yersinia and Borrelia share amino acid sequence homology that includes binding motifs to HLA-DR molecules and T-cell receptor. Thyroid 2006 16 225 236.